Literature DB >> 23087572

Feasibility of screening for urinary abnormalities as a part of school health appraisal.

A Iyengar1, B R Goud, N Kamath, K D Phadke, A Kasthuri.   

Abstract

Entities:  

Year:  2012        PMID: 23087572      PMCID: PMC3459541          DOI: 10.4103/0971-4065.98807

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN: 0971-4065


× No keyword cloud information.
Sir, Urinary abnormalities can be asymptomatic in children and identified only by screening tests.[1] Several South East Asian countries perform urine screening as a part of regular health evaluation for school children. This is an effective method for prevention and early detection of chronic kidney disease.[2-4] No study has been conducted in India on urine screening in school children. The objectives were to study the prevalence of asymptomatic proteinuria and hematuria in school children and assess the feasibility of screening urine as a part of annual school health appraisal. We conducted a cross-sectional study from October 2008 to June 2009 among school children aged 5-16 years from schools in the urban slums of Bangalore. After obtaining informed consent from parents and teachers, a mid-stream sample of urine was freshly collected in a sterile container and tested within 30 minutes for proteinuria and hematuria using URS-9 (Teco diagnostics) dipsticks. Proteinuria 1+ to 4+ (30->2000 mg/dl) and hematuria 1+ to 4+ (10-200 RBC/μl) were considered abnormal. Hematuria was confirmed by microscopic examination. The reevaluation of isolated microscopic hematuria is recommended weekly for 2 weeks to look for persistence of hematuria.[56] However, we were able to reevaluate only after 3 months. A total of 1597 children were included in this study. The male to female ratio was 1:1. A total of 752 (47.27%) children were between 5 and 10 years of age and 845 (52.72%) were between 11 and 16 years. The prevalence of urinary abnormalities on initial evaluation was 7.82% (95% CI 3.2, 9.4). Proteinuria and hematuria on the first evaluation were seen in 1.9% and 5.8%, respectively. There was a significantly higher prevalence of urinary abnormalities in older children (9.8%), compared to younger children (5.18%) (P<0.01). Only 54.5% of the children with urinary abnormalities were available for re-evaluation. The prevalence of urinary abnormalities reduced from 7.8% to 1.9%. Those children who had persistent urinary abnormalities were advised to come to the Pediatric Nephrology OPD for further evaluation. The prevalence of proteinuria and hematuria in our study population is comparable with other studies where the prevalence of hematuria varies from 0.5-7.2%.[2-47-9] The prevalence of urinary abnormalities was significantly higher in the older age group and this was in concordance with other studies.[489] Persistent urinary abnormalities were found in 1.98% of children. This may be falsely low as only 55% were reassessed. The reduction in the prevalence may be due to transient abnormalities. The feasibility of screening was assessed. Urine samples were obtained in all children. However, repeat evaluation could be done only in 55%. Younger children needed assistance with urine collection. The dipsticks could be split vertically into two parts to reduce the cost. The cost of urine screening was Rs. 10 per child and the time taken for screening was 5 to 7 minutes per child. Hence, urine screening is a simple, noninvasive, inexpensive, and feasible test which can be incorporated into the school health appraisal process. We concluded that urine screening is a simple and feasible method for diagnosis of urinary abnormalities in asymptomatic children which requires periodic re-evaluation. The limitations of our study were that an early morning urine sample was not collected. Repeat evaluation was done only after a gap of 3 months. Only 55% of children with urinary abnormalities were available for repeat evaluation. Further evaluation for the etiology of proteinuria and hematuria could add significance to the screening of urinary abnormalities in these children.
  8 in total

1.  Urinary screening of elementary and junior high-school children over a 13-year period in Tokyo.

Authors:  M Murakami; H Yamamoto; Y Ueda; K Murakami; K Yamauchi
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 2.  Consensus statement on evaluation of hematuria.

Authors:  K D Phadke; M Vijayakumar; Jyoti Sharma; Arpana Iyengar
Journal:  Indian Pediatr       Date:  2006-11       Impact factor: 1.411

Review 3.  Screening for CKD in children: a global controversy.

Authors:  Ronald J Hogg
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

Review 4.  Role of urinary screening programmes in children in the prevention of chronic kidney disease.

Authors:  H K Yap; C M Quek; Q Shen; V Joshi; K S Chia
Journal:  Ann Acad Med Singapore       Date:  2005-01       Impact factor: 2.473

5.  Proteinuria in South Asian children: prevalence and determinants.

Authors:  Tazeen H Jafar; Nish Chaturvedi; Juanita Hatcher; Iqtidar Khan; Anas Rabbani; Abdul Qayum Khan; Ronald Portman; Christopher H Schmid; Andrew S Levey
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

Review 6.  School urinalysis screening in Korea.

Authors:  Byoung-Soo Cho; Sung-Do Kim
Journal:  Nephrology (Carlton)       Date:  2007-12       Impact factor: 2.506

Review 7.  Evaluation of hematuria in children.

Authors:  Kevin E C Meyers
Journal:  Urol Clin North Am       Date:  2004-08       Impact factor: 2.241

8.  Efficacy of urine screening at school: experience in Shanghai, China.

Authors:  Yi-Hui Zhai; Hong Xu; Guang-Hua Zhu; Min-Jiang Wei; Bing-Chun Hua; Qian Shen; Jia Rao; Jie Ge
Journal:  Pediatr Nephrol       Date:  2007-10-18       Impact factor: 3.714

  8 in total
  1 in total

1.  Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin.

Authors:  Dulce M Macias Diaz; Myriam Del Carmen Corrales Aguirre; Ana Lilian Reza Escalera; Maria Teresa Tiscareño Gutiérrez; Itzel Ovalle Robles; Mariana Jocelyn Macías Guzmán; Andrea L García Díaz; Mauricio C Gutiérrez Peña; Andrea Natalia Alvarado-Nájera; Israel González Domínguez; Juan Carlos Villavicencio-Bautista; Angela Azucena Herrera Rodríguez; Ricardo Marín-García; Francisco Javier Avelar González; Alfredo Chew Wong; Elba Galván Guerra; Rodolfo Delgadillo Castañeda; Carlos Alberto Prado Aguilar; Leslie P Zúñiga-Macías; José Manuel Arreola Guerra
Journal:  Clin Kidney J       Date:  2022-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.